Revive Therapeutics Ltd (RVVTF)

[Stockrocketer]

22 trading days to PHASE III Bucillamine Covid-19 treatment output and FDA approval on 1-th. May 2021, the study will complete go public at 1-th. August 2021.
Bucillamine is a first drug with 95% efficacy to threat the Covid-19 virus and will be used worldwide.
The facts:
1, 2 weeks mortality after vaccination 5% of people, 35% seniors mortality within the age 70-90+, 98% of mortality within 4 years
2, AstraZeneca vaccine, now renamed Vaxzevria, inflicts 2 weeks mortality after vaccination 10% of people, 55-60% seniors mortality within the age 70-90+, 100% of mortality within 4 years
3, BILL GATES and GAVI, COVAX : "...If we make very good job, we will reduce population around 10-15% yearly, if we make very good job!...."
What contains the vaccine?
1, Mercury
2, TitaniumDioxide
3, AluminiumSulphide
4, MRC5 - abruptly killed embrya´s DNA
5, adenovirus vector with mRNA CRISPER DNA scissors
6, PROFUSA NANOBOTS AND BIOSENSORS
7, Hydrogels and Lipide package

AstraZeneca post vaccination embolia, trombose and infarctus miocardi are caused with PROFUSA NANOBOTS AND BIOSENSORS malfunction, they can make this on remote command in 5 minutes, but in this case as a malfunction without a remote command.